Stock AnalizRepligen (RGEN) earnings for the quarter ended September 2026: EPS beats estimates
Repligen reported results for the quarter ended September 2026 on October 27, 2026. Adjusted earnings per share came in at $0.53 against the analysts’ average forecast of $0.46, a beat of 14.5%.
Revenue for the quarter was $209 million, up 10.9% from $189 million in the same quarter a year earlier.
The market’s verdict: the stock fell 2.4% on the first trading day after the report.
The last four quarters
Repligen has beaten the analysts’ EPS forecast in 4 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $0.53 | $0.46 | +14.5% | +11% | −2.4% |
| Jun 2026 | $0.54 | $0.45 | +20.4% | +12% | +7.8% |
| Mar 2026 | $0.48 | $0.39 | +22.9% | +15% | +6.4% |
| Dec 2025 | $0.49 | $0.44 | +10.4% | +18% | −2.4% |
What comes next
Analysts expect EPS of $0.52 for the next quarter on average and $2.07 for the fiscal year ending December 31, 2026.
The average analyst price target is $203.21, 21% above the current price of $167.79.
Valuation and score
Repligen scores 1.8 out of 5 overall on Stock Analiz (weak), and its intrinsic value under moderate assumptions is about 76% below the current market value. Full Repligen analysis with 10 years of financials
Frequently asked questions
What was Repligen’s EPS for the quarter ended September 2026?
$0.53 adjusted per share, against an analyst consensus of $0.46.
How much revenue did Repligen report?
$209 million, up 10.9% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.